Get startedLog in
    Picture of Allena Pharmaceuticals logo

    ALNAQ — Allena Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Allena Pharma Announces Initial Data From Phase 1 Trial Of ALLN-346

    Picture of Allena Pharmaceuticals logoAllena Pharmaceuticals
    30/11/2020 13:24
    Nov 30 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS ANNOUNCES INITIAL DATA FROM PHASE 1
TRIAL
OF ALLN-346
    * ALLENA PHARMACEUTICALS INC - SINGLE-ASCENDING DOSES OF
ALLN-346
ORAL ENZYME WELL-TOLERATED
    * ALLENA PHARMACEUTICALS INC - NON-ABSORPTION OF ALLN-346
DEMONSTRATED
    * ALLENA PHARMACEUTICALS INC - ADVANCING TO PHASE 1B
MULTIPLE-ASCENDING DOSE STUDY AND PHASE 2 PROOF-OF-CONCEPT TRIAL

Source text for Eikon:  ID:nGNX7KStDD 
Further company coverage:  ALNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Allena Pharmaceuticals

    See all news